搜索

联系我们

  • 公司地址: 上海普陀区中江路879弄(天地科技园)4号楼B座3层
    乘车路线: 行车路线: 中内环金沙江路口出,沿金沙江路行至中江路879弄(天地科技园区内)。附近地铁:13号线大渡河路站4号口出站,至中江路天地科技园。
    客服咨询: 点击这里给我发消息
双特异性抗体/DC-CIK技术平台
 

双特异性抗体是含有两种特异性抗原结合位点的双功能抗体。我们通过化学交联法将抗CD3单抗与曲妥珠单抗交联,获得了对肿瘤细胞和淋巴细胞的双向识别作用的双特异抗体。此双特异性抗体一方面通过CD3单抗识别CIK细胞;另一方面,通过曲妥珠单抗识别肿瘤表面HER2受体。


在DC-CIK细胞体外诱导、培养的**阶段加入该双特异抗体,双特异抗体即通过抗CD3抗体结合到CIK细胞表面,CIK细胞回输到体内后,其表面的双特异抗体将CIK细胞靶向募集到肿瘤细胞表面,从而提高CIK细胞对肿瘤细胞的识别和杀伤活性。


技术特点

l   制备技术相对简单;

l   利用抗体-抗原的强大亲和力,大大提高DC-CIK细胞对肿瘤细胞的识别和杀伤机会。



Bispecific antibody / DC-CIK technology

A bispecific antibody is a bifunctional antibody that contains two specific antigen binding sites. We cross-linked anti-CD3 monoclonal antibody with trastuzumab by chemical cross-linking, and obtained bi-specific antibodies for bi-directional recognition of tumor cells and lymphocytes. This bispecific antibody recognizes CIK cells via CD3 target and recognizes tumor cells via HER2 receptor.

In the final stage of DC-CIK cells culturing, the bispecific antibody was added and binds to the surface of CIK cells through anti-CD3 antibody. After transfusion, the  cells were recruited to tumor cells through bispecific antibody, thereby enhancing the recognition and killing activity of CIK cells to tumor cells.

 

Technical features

1.   The preparation technique is relatively simple

2.   The strong affinity of antibody to antigen greatly improves the DC-CIK cells on tumor

      cell recognition and killing opportunities



分享到:
  • 电话咨询
您是第 53305 位访客!